This study indicates that SON is overexpressed and plays a critical role in the proliferation, survival, and tumorigenicity of pancreatic cancer cells, suggesting that SON is a novel therapeutic molecular target for pancreatic cancer. The gene discussed is SON; the disease is familial pancreatic carcinoma.